Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.28 USD | +0.98% | +3.23% | +59.18% |
05-13 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
05-13 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TSCAN THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +0.98% | +3.23% | +59.18% | +190.00% | - | 530M |
- Stock Market
- Equities
- TCRX Stock
- Charts TScan Therapeutics, Inc.
- Relative Strength Chart